首页> 外文期刊>Experimental and clinical transplantation >Use of Methylene Blue to Treat Hypovolemic Shock Followed by Ischemia-Reperfusion Injury in the Postoperative Orthotopic Liver Transplant Patient: A Case Report
【24h】

Use of Methylene Blue to Treat Hypovolemic Shock Followed by Ischemia-Reperfusion Injury in the Postoperative Orthotopic Liver Transplant Patient: A Case Report

机译:亚甲蓝治疗原位肝移植术后患者的低血容量性休克继发缺血再灌注损伤的病例报告

获取原文
           

摘要

A 57-year-old female patient received elective liver transplant due to nonalcoholic steatohepatitis com?-plicated by hepatocellular carcinoma. Her pre?-operative Model for End-Stage Liver Disease score was 11. The total transplant ischemic time was 10 hours and 35 minutes, and the warm ischemic time was 35 minutes. Even with aggressive fluid overload and use of high concentrations of vasoactive amines, the patient developed possible primary graft dysfunction with poor response to fluids and vasopressor support, suggesting vasoplegic syndrome. On the basis of the hypothesis of vasoplegic syndrome, the patient received methylene blue intravenously (100 mg bolus for 12 h/1.5 mg/kg). The catastrophic situation was controlled. The patient’s urine output markedly improved, she was subsequently weaned from vasoactive support, and mechanical ventilation was discontinued 2 days later. The patient was discharged on the 20th postoperative day.
机译:一名57岁的女性患者因非酒精性脂肪性肝炎并发肝细胞癌而接受了选择性肝移植。她的终末期肝病术前模型评分为11。总移植缺血时间为10小时35分钟,温暖缺血时间为35分钟。即使出现严重的体液超负荷和使用高浓度的血管活性胺,患者仍可能发生原发性移植物功能障碍,对体液和血管升压药的支持不良,提示存在血管性腿病综合征。根据血管收缩综合征的假设,患者静脉注射亚甲蓝(100毫克推注剂量,持续12 h / 1.5 mg / kg)。灾难性的局势得到了控制。患者的尿量明显改善,随后她从血管活性支持中断奶,并在2天后中断了机械通气。病人在术后第20天出院。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号